410 related articles for article (PubMed ID: 11163815)
1. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study.
Glueck CJ; Phillips H; Cameron D; Sieve-Smith L; Wang P
Fertil Steril; 2001 Jan; 75(1):46-52. PubMed ID: 11163815
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin.
Glueck CJ; Wang P; Goldenberg N; Sieve-Smith L
Hum Reprod; 2002 Nov; 17(11):2858-64. PubMed ID: 12407039
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
Glueck CJ; Sieve L; Zhu B; Wang P
Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
[TBL] [Abstract][Full Text] [Related]
4. Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.
Ramidi G; Khan N; Glueck CJ; Wang P; Goldenberg N
Transl Res; 2009 Jan; 153(1):33-43. PubMed ID: 19100956
[TBL] [Abstract][Full Text] [Related]
5. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.
Glueck CJ; Wang P; Kobayashi S; Phillips H; Sieve-Smith L
Fertil Steril; 2002 Mar; 77(3):520-5. PubMed ID: 11872206
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin.
Glueck CJ; Wang P; Goldenberg N; Sieve L
Clin Appl Thromb Hemost; 2004 Oct; 10(4):323-34. PubMed ID: 15497018
[TBL] [Abstract][Full Text] [Related]
7. Metformin reduces abortion in pregnant women with polycystic ovary syndrome.
Khattab S; Mohsen IA; Foutouh IA; Ramadan A; Moaz M; Al-Inany H
Gynecol Endocrinol; 2006 Dec; 22(12):680-4. PubMed ID: 17162710
[TBL] [Abstract][Full Text] [Related]
8. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy.
Glueck CJ; Goldenberg N; Wang P; Loftspring M; Sherman A
Hum Reprod; 2004 Mar; 19(3):510-21. PubMed ID: 14998944
[TBL] [Abstract][Full Text] [Related]
9. Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome.
Glueck CJ; Goldenberg N; Pranikoff J; Khan Z; Padda J; Wang P
Curr Med Res Opin; 2013 Jan; 29(1):55-62. PubMed ID: 23205605
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort study.
Scherneck S; Schlinke N; Beck E; Grupe K; Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2018 Oct; 81():79-83. PubMed ID: 30017588
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome.
Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Roberts KA; Nestler JE
J Clin Endocrinol Metab; 2002 Feb; 87(2):524-9. PubMed ID: 11836280
[TBL] [Abstract][Full Text] [Related]
12. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
[TBL] [Abstract][Full Text] [Related]
13. Effect of metformin on early pregnancy loss in women with polycystic ovary syndrome.
Al-Biate MA
Taiwan J Obstet Gynecol; 2015 Jun; 54(3):266-9. PubMed ID: 26166338
[TBL] [Abstract][Full Text] [Related]
14. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications.
De Leo V; Musacchio MC; Piomboni P; Di Sabatino A; Morgante G
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):63-6. PubMed ID: 21530058
[TBL] [Abstract][Full Text] [Related]
15. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.
Cassina M; Donà M; Di Gianantonio E; Litta P; Clementi M
Hum Reprod Update; 2014; 20(5):656-69. PubMed ID: 24861556
[TBL] [Abstract][Full Text] [Related]
16. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.
Glueck CJ; Pranikoff J; Aregawi D; Wang P
Fertil Steril; 2008 Mar; 89(3):625-34. PubMed ID: 17678910
[TBL] [Abstract][Full Text] [Related]
17. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.
Glueck CJ; Bornovali S; Pranikoff J; Goldenberg N; Dharashivkar S; Wang P
Diabet Med; 2004 Aug; 21(8):829-36. PubMed ID: 15270785
[TBL] [Abstract][Full Text] [Related]
18. In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study.
Diav-Citrin O; Steinmetz-Shoob S; Shechtman S; Ornoy A
Reprod Toxicol; 2018 Sep; 80():85-91. PubMed ID: 29857030
[TBL] [Abstract][Full Text] [Related]
19. Effect of metformin on miscarriage in pregnant patients with polycystic ovary syndrome.
Sohrabvand F; Shariat M; Haghollahi F; Bagheri B
West Indian Med J; 2009 Nov; 58(5):433-6. PubMed ID: 20441061
[TBL] [Abstract][Full Text] [Related]
20. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.
Glueck CJ; Wang P; Fontaine R; Tracy T; Sieve-Smith L
Metabolism; 1999 Apr; 48(4):511-9. PubMed ID: 10206447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
